MACC

American College of Cardiology Program to Increase Cholesterol Screenings

Retrieved on: 
Tuesday, September 12, 2023
ACC, Amgen, College, Cardiovascular disease, American Heart Association, American College of Cardiology, Registry, Cholesterol, Stroke, MACC, FACC, NCDR, Woman, Multimedia, Improvement, Doctor of Philosophy, Health policy, Practice Fusion, Science, Outline, ECDP, Guideline, Patient, Risk, Practice management, LDL, Knowledge, ASCVD, Moyamoya disease, American College, Health, Medical device, Pharmaceutical industry, Nursing, Esperies, MD, Cardiology

WASHINGTON, Sept. 12, 2023 /PRNewswire/ -- The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, "Driving Urgency in LDL Screening," to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular disease to help clinicians identify those who need treatment in accordance with medical guidelines.

Key Points: 
  • The higher a person's LDL, or "bad" cholesterol, the higher the chance of developing heart disease or having a heart attack or stroke.
  • Evidence has shown that lowering LDL levels through lifestyle changes and/or medications can reduce a person's risk of atherosclerotic cardiovascular disease (ASCVD).
  • We are proud to have joined forces with the American College of Cardiology and Esperion on this collaborative effort to increase doctor-directed screening and, ultimately, helping to improve cardiovascular care and patient outcomes."
  • The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all.

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

Retrieved on: 
Tuesday, September 5, 2023
Knowledge, Moyamoya disease, SDAC, Madison, University, Therapy, Heart failure, Myocardial infarction, BCDA, DSMB, Hospital, Principal investigator, Bell P-76, Stroke, Survival, HF, MACC, University of Wisconsin–Madison, Cell, GDMT, Patient, Heart, FS, FDA, Death, Safety, Jan Vansina, Pharmaceutical industry, Dietary supplement, MD, Medicine

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP ® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation for the treatment of heart failure of reduced ejection fraction (HFrEF).

Key Points: 
  • SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP ® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation for the treatment of heart failure of reduced ejection fraction (HFrEF).
  • This review was based on the three-tiered Finkelstein-Schoenfeld (FS) hierarchical analysis of 12-month data, whose composite score comprises the primary efficacy endpoint of the CardiAMP HF study.
  • These limited interim results related to the primary efficacy endpoint have been shared with the Co-National Principal Investigators of the study.
  • Knowledge from these interim details may be incorporated in its ongoing development plans for its autologous CardiAMP and allogeneic CardiALLO cell therapy programs.

Globalgig’s Orchestra Platform Now Available in the Microsoft Azure Marketplace

Retrieved on: 
Wednesday, August 23, 2023
Apps, Applications, Technology, Mobile, Wireless, Telecommunications, Software, Networks, Internet, IOT (Internet of Things), Data Management, Orchestra, Software as a service, SIM, Marketplace, Type 2, Mobile virtual network enabler, Internet of things, MACC, Microsoft, Human, UCAA, Organization, Azure, SASE, API, Video game, Mobile phone, Music

Globalgig, a network platform and connectivity provider for global enterprises, announced today the availability of its Orchestra platform in the Microsoft Azure Marketplace, an online market for buying and selling cloud solutions certified to run on Azure.

Key Points: 
  • Globalgig, a network platform and connectivity provider for global enterprises, announced today the availability of its Orchestra platform in the Microsoft Azure Marketplace, an online market for buying and selling cloud solutions certified to run on Azure.
  • The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.
  • This eligibility allows organizations to procure Globalgig managed network services directly through the Azure Marketplace, while fulfilling Globalgig’s Marketplace consumption commitment.
  • Additionally, Globalgig’s software and systems are SOC2, Type II compliant
    Jake Zborowski, General Manager, Microsoft Azure Platform at Microsoft Corporation said: “We’re pleased to welcome Globalgig to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe.

International Scholarship and Tuition Services, Inc. Announces 2023 Starfish Awardees

Retrieved on: 
Monday, August 21, 2023
Campaign, ISTS, Safety, MACC, Organization, Friends, Animal, Benjamin A. Gilman International Scholarship, Starfish, Pharmaceutical industry

NASHVILLE, Tenn., Aug. 21, 2023 /PRNewswire-PRWeb/ -- International Scholarship and Tuition Services, Inc. (ISTS) has named Friends of MACC and Nashville Diaper Connection recipients of the 2023 Starfish Campaign awards, the company's annual giving initiative.

Key Points: 
  • Employees nominate charities within their communities to receive financial and volunteer support as part of annual campaign, now it its 14th year
    NASHVILLE, Tenn., Aug. 21, 2023 /PRNewswire-PRWeb/ -- International Scholarship and Tuition Services, Inc. (ISTS) has named Friends of MACC and Nashville Diaper Connection recipients of the 2023 Starfish Campaign awards, the company's annual giving initiative.
  • In selecting these organizations as recipients, ISTS commits to volunteer engagement from staff throughout the year as well as a one-time monetary contribution.
  • Nashville Diaper Connection is a nonprofit diaper bank that that distributes free diapers to families in need through a network of partner agencies in Middle Tennessee.
  • Through the Starfish Campaign, ISTS has donated nearly $20,000 to more than 35 organizations since 2010.

SkyHive Now Available in the Microsoft Azure Marketplace

Retrieved on: 
Thursday, August 17, 2023
Software, Technology, Artificial Intelligence, SkyHive, MACC, Organization, Retraining, Microsoft, Fortune 500, Video game, Azure

SkyHive deploys its ethical AI technology to Fortune 500/Global 2000 clients, many of whom are Microsoft clients.

Key Points: 
  • SkyHive deploys its ethical AI technology to Fortune 500/Global 2000 clients, many of whom are Microsoft clients.
  • “Inclusion in the Microsoft Azure Marketplace will mean that even more organizations will be able to transform from jobs to skills,” says SkyHive Founder and CEO Sean Hinton.
  • Jake Zborowski, General Manager, Microsoft Azure Platform at Microsoft Corp. said, “We’re pleased to welcome SkyHive to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe.
  • Azure Marketplace offers world-class quality experiences from global trusted partners with solutions tested to work seamlessly with Azure.”

HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting

Retrieved on: 
Monday, July 24, 2023
Charleston Area Medical Center, CT scan, Cardiac imaging, University, Culture, MACC, FACC, Booth, CCTA, Research, Ability, SCCT, Plaque, Physician, Cardiology, University of British Columbia, AM, Coronary artery disease, Medical imaging, Doctor of Philosophy, Patient, MPH

MOUNTAIN VIEW, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and physiologic insights, today announced that new data on HeartFlow Plaque Analysis and its RoadMapTM Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA.

Key Points: 
  • MOUNTAIN VIEW, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and physiologic insights, today announced that new data on HeartFlow Plaque Analysis and its RoadMapTM Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA.
  • “The data being presented at SCCT are the latest findings in a robust body of evidence that show HeartFlow technologies help clinicians further improve diagnostic accuracy and clinical decision-making to ensure the right patients are getting the right care at the right time,” said Campbell Rogers, Chief Medical Officer of HeartFlow.
  • Featured speakers include Jonathon Leipsic, M.D., FSCCT, former president of SCCT; Jagat Narula, M.D., PhD, MACC, Executive Vice President and Chief Academic Officer at UTHealth Houston; Wesley O’Neal, M.D., MPH, FACC, Director, Cardiac CT and Nuclear Cardiology at Cone Health Heart & Vascular Center and Sarah Rinehart, M.D., FACC, FSCCT, Director of Cardiac Imaging, Director of Cardiology Fellowship at Charleston Area Medical Center.
  • Company representatives will also be available during the conference at Booth 207.

Dynatrace Announces Expanded Multi-Year Consumption Commitment and Go-To-Market Partnership with Microsoft

Retrieved on: 
Wednesday, July 19, 2023
Software, Internet, Marketing, Data Management, Communications, Technology, Other Technology, Security, Cloud, Cosmos, IDC, Partnership, Cosmos DB, MACC, Microsoft, Organization, DT, Corporation, Microsoft Azure, Linux, GTM, NYSE, Automation, Video game, Azure, Dynatrace

Dynatrace (NYSE: DT), the leader in unified observability and security, today announced an expanded multi-year consumption commitment and go-to-market (GTM) partnership with Microsoft, with joint sales enablement and marketing, including campaigns, events, webinars, and customer solution workshops and hands-on labs.

Key Points: 
  • Dynatrace (NYSE: DT), the leader in unified observability and security, today announced an expanded multi-year consumption commitment and go-to-market (GTM) partnership with Microsoft, with joint sales enablement and marketing, including campaigns, events, webinars, and customer solution workshops and hands-on labs.
  • The goal is to meet the growing demand from joint customers worldwide for the Dynatrace® platform on Microsoft Azure to accelerate cloud migration and optimization initiatives.
  • Customers can use their Microsoft Azure Consumption Commitment (MACC) to purchase the Dynatrace platform through the Azure Marketplace, simplifying purchasing and contract management.
  • “Through our partnership, customers will realize deep insights and automation across their technology stack, enhancing operational efficiencies and digital experiences.

Tanium Recognized as Winner of the 2023 Microsoft US Rising Azure Technology Partner of the Year Award

Retrieved on: 
Wednesday, June 28, 2023
Data Management, Security, Technology, Other Technology, Software, Networks, Cloud, Sentinel, Microsoft, Inspiration, Partnership, Security association, Ernst & Young Entrepreneur of the Year Award, Policy, MACC, Organization, Risk, Microsoft Azure, Azure, ISV, MISA, Video game, Online shopping, Tanium

Tanium and Microsoft solutions are transforming the way organizations secure and manage their vast environments by delivering a fast, extensible, and effective endpoint management solution - delivered from the Microsoft Azure cloud.

Key Points: 
  • Tanium and Microsoft solutions are transforming the way organizations secure and manage their vast environments by delivering a fast, extensible, and effective endpoint management solution - delivered from the Microsoft Azure cloud.
  • The Rising Azure Technology Partner of the Year Award is distinguished upon a technology partner (ISV) that has demonstrated strong customer focus and impact by building on Microsoft Azure as their primary cloud platform and scaling their solution by selling with Microsoft.
  • “We would like to extend our congratulations to the winners and finalists of the 2023 Microsoft Partner of the Year Awards!” said Nina Harding, corporate vice president, Microsoft US global partner solutions.
  • Tanium is available in the Microsoft Commercial Marketplace, an online store providing applications and services for use on Microsoft Azure.

FDA Proposes New, Easy-to-Read Medication Guide for Patients, Patient Medication Information

Retrieved on: 
Tuesday, May 30, 2023
Vaccine, Medical Information Technology, China Biologic Products, Disulfiram-like drug, Office of Inspector General, U.S. Department of Health and Human Services, Medication, Human services, Public, MACC, Intelligence, Food, Cosmetics, Multimedia, Animal, Plasma protein binding, Death, Dietary supplement, Patient, Blood, Translation, Heated tobacco product, Research, Health, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Safety, Pharmaceutical industry, Medical device

SILVER SPRING, Md., May 30, 2023 /PRNewswire/ -- Providing people with accurate and timely information to help them take their prescription medications safely and effectively is an important priority for the U.S. Food and Drug Administration. Evidence suggests that more easy-to-read information can help patients reduce preventable adverse drug reactions and improve health outcomes.

Key Points: 
  • Evidence suggests that more easy-to-read information can help patients reduce preventable adverse drug reactions and improve health outcomes.
  • Currently, patients may receive one or more types of written information for prescription drugs and certain biological products, depending on the medication they are prescribed.
  • Studies have found that the current system for written information for prescription drugs and certain biological products can be confusing, conflicting, incomplete, or repetitive.
  • We encourage public comments for the Medication Guide: Patient Medication Information proposed rule during the public comment period.

ITRAK 365 Breaks New Ground with Transactable Capability on Microsoft AppSource and Azure Marketplace

Retrieved on: 
Monday, May 29, 2023
Safety, MACC, AB, Municipality, Microsoft, Energi Mine, EHS, Software, Video game, Mining

CALGARY, AB, May 29, 2023 /PRNewswire/ - ITRAK 365, a leading software provider for Safety and Compliance solutions, is excited to announce its new transact capability across both Microsoft's AppSource and Azure Marketplaces.

Key Points: 
  • CALGARY, AB, May 29, 2023 /PRNewswire/ - ITRAK 365, a leading software provider for Safety and Compliance solutions, is excited to announce its new transact capability across both Microsoft's AppSource and Azure Marketplaces.
  • "We're thrilled to reach this significant milestone with Microsoft," said Trevor Nimegeers, President and CEO of ITRAK 365.
  • "We are excited about how much easier this will make procuring ITRAK 365 for our customers.
  • These transactable capabilities allow Microsoft customers to allocate their Microsoft Azure Consumption Commitments (MACC) to the purchase of ITRAK 365 software.